1. Home
  2. FSFG vs SABS Comparison

FSFG vs SABS Comparison

Compare FSFG & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Savings Financial Group Inc.

FSFG

First Savings Financial Group Inc.

N/A

Current Price

$31.86

Market Cap

221.5M

Sector

Finance

ML Signal

N/A

Logo SAB Biotherapeutics Inc.

SABS

SAB Biotherapeutics Inc.

HOLD

Current Price

$4.12

Market Cap

187.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSFG
SABS
Founded
2008
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
221.5M
187.6M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
FSFG
SABS
Price
$31.86
$4.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$31.50
$9.80
AVG Volume (30 Days)
11.3K
370.7K
Earning Date
01-28-2026
11-13-2025
Dividend Yield
1.98%
N/A
EPS Growth
67.68
N/A
EPS
3.32
N/A
Revenue
$84,223,000.00
$114,698.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$9.76
N/A
Revenue Growth
23.59
N/A
52 Week Low
$21.63
$1.00
52 Week High
$34.10
$6.60

Technical Indicators

Market Signals
Indicator
FSFG
SABS
Relative Strength Index (RSI) 51.24 63.00
Support Level $31.81 $3.93
Resistance Level $34.10 $4.21
Average True Range (ATR) 0.54 0.28
MACD 0.01 0.02
Stochastic Oscillator 37.07 82.17

Price Performance

Historical Comparison
FSFG
SABS

About FSFG First Savings Financial Group Inc.

First Savings Financial Group Inc provides various banking services to individuals and business customers in southern Indiana. The bank accepts deposits from the general public & uses those funds, along with other borrowings, mainly to originate a residential mortgage, commercial mortgage, construction, commercial business, & consumer loans, and to a lesser extent, to invest in mortgage-backed securities and other debt securities. The company conducts lending and deposit activities mainly with individuals and small businesses in its market area. The bank operates in two segments: core banking, which accounts for the majority of revenue, and SBA lending.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: